Literature DB >> 15650178

Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor.

Akiko Yanagiya1, Qingmei Jia, Seii Ohka, Hitoshi Horie, Akio Nomoto.   

Abstract

The poliovirus (PV)-induced cytopathic effect (CPE) was blocked in neural cells but not in HeLa cells by the addition of monoclonal antibody (MAb) against PV or the human PV receptor (CD155) 2 h postinfection (hpi). Since each MAb has the ability to block viral infection, no CPE in PV-infected neural cells appeared to result from the blockade of multiple rounds of viral replication. Pulse-labeling experiments revealed that virus-specific protein synthesis proceeded 5 hpi with or without MAbs. However, in contrast to the results obtained without MAbs, virus-specific protein synthesis with MAbs was not detected 7 hpi. Shutoff of host translation was also not observed in the presence of MAbs. Western blot analysis showed that 2Apro, the viral protein which mediates the cleavage of eukaryotic translation initiation factor eIF4G, was still present 11 hpi. However, intact eIF4G appeared 11 hpi. An immunocytochemical study indicated that 2Apro was detected only in the nucleus 11 hpi. These results suggest that neural cells possess protective response mechanisms against PV infection as follows: (i) upon PV infection, neural cells produce a factor(s) to suppress PV internal ribosome entry site activity by 7 hpi, (ii) a factor which supports cap-dependent translation for eIF4G may exist in infected cells when no intact eIF4G is detected, and (iii) the remaining 2Apro is not effective in cleaving eIF4G because it is imported into the nucleus by 11 hpi.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650178      PMCID: PMC544096          DOI: 10.1128/JVI.79.3.1523-1532.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus.

Authors:  E A Tolskaya; T A Ivannikova; M S Kolesnikova; S G Drozdov; V I Agol
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A.

Authors:  S J Hambidge; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  ELECTRON MICROSCOPIC STUDY OF THE FORMATION OF POLIOVIRUS.

Authors:  S DALES; H J EGGERS; I TAMM; G E PALADE
Journal:  Virology       Date:  1965-07       Impact factor: 3.616

4.  Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity.

Authors:  S F Yu; P Benton; M Bovee; J Sessions; R E Lloyd
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

Review 5.  Genetics of poliovirus.

Authors:  E Wimmer; C U Hellen; X Cao
Journal:  Annu Rev Genet       Date:  1993       Impact factor: 16.830

6.  Protein processing map of poliovirus.

Authors:  M A Pallansch; O M Kew; B L Semler; D R Omilianowski; C W Anderson; E Wimmer; R R Rueckert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.

Authors:  H Toyoda; M J Nicklin; M G Murray; C W Anderson; J J Dunn; F W Studier; E Wimmer
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

8.  Studies on dicistronic polioviruses implicate viral proteinase 2Apro in RNA replication.

Authors:  A Molla; A V Paul; M Schmid; S K Jang; E Wimmer
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

9.  Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs.

Authors:  R Hanecak; B L Semler; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

10.  La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.

Authors:  K Meerovitch; Y V Svitkin; H S Lee; F Lejbkowicz; D J Kenan; E K Chan; V I Agol; J D Keene; N Sonenberg
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  6 in total

1.  2A protease is not a prerequisite for poliovirus replication.

Authors:  Hiroko Igarashi; Yasuko Yoshino; Miwako Miyazawa; Hitoshi Horie; Seii Ohka; Akio Nomoto
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  Characterization of the New World monkey homologues of human poliovirus receptor CD155.

Authors:  Shaukat Khan; Xiaozhong Peng; Jiang Yin; Ping Zhang; Eckard Wimmer
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

3.  Scavenger receptor B2 is a cellular receptor for enterovirus 71.

Authors:  Seiya Yamayoshi; Yasuko Yamashita; Jifen Li; Nobutaka Hanagata; Takashi Minowa; Taro Takemura; Satoshi Koike
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 4.  A second look at cellular mRNA sequences said to function as internal ribosome entry sites.

Authors:  Marilyn Kozak
Journal:  Nucleic Acids Res       Date:  2005-11-28       Impact factor: 16.971

5.  Differential In Vitro Infection of Neural Cells by Astroviruses.

Authors:  Andrew B Janowski; Robyn S Klein; David Wang
Journal:  mBio       Date:  2019-07-09       Impact factor: 7.867

Review 6.  Molecular aspects of poliovirus pathogenesis.

Authors:  Akio Nomoto
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2007-12       Impact factor: 3.493

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.